Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration.

Numakawa T, Matsumoto T, Numakawa Y, Richards M, Yamawaki S, Kunugi H.

J Toxicol. 2011;2011:405194. doi: 10.1155/2011/405194. Epub 2011 May 31.

2.

Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease.

Garbayo E, Ansorena E, Lanciego JL, Blanco-Prieto MJ, Aymerich MS.

Mov Disord. 2011 Aug 15;26(10):1943-7. doi: 10.1002/mds.23793. Epub 2011 Jun 9.

PMID:
21661048
3.

Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes.

Kaur H, Donaghue KC, Chan AK, Benitez-Aguirre P, Hing S, Lloyd M, Cusumano J, Pryke A, Craig ME.

Diabetes Care. 2011 Jun;34(6):1400-2. doi: 10.2337/dc11-0103. Epub 2011 Apr 22.

4.

The 712A/G polymorphism of Brain-derived neurotrophic factor is associated with Parkinson's disease but not Major Depressive Disorder in a Chinese Han population.

Chen L, Wang Y, Xiao H, Wang L, Wang C, Guo S, Zhao Y, Hua P, Liu W, Zhang N.

Biochem Biophys Res Commun. 2011 May 6;408(2):318-21. doi: 10.1016/j.bbrc.2011.04.030. Epub 2011 Apr 12.

PMID:
21510922
5.

Prostaglandins and inflammation.

Ricciotti E, FitzGerald GA.

Arterioscler Thromb Vasc Biol. 2011 May;31(5):986-1000. doi: 10.1161/ATVBAHA.110.207449. Review.

6.

Diabetes and the risk of developing Parkinson's disease in Denmark.

Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B.

Diabetes Care. 2011 May;34(5):1102-8. doi: 10.2337/dc10-1333. Epub 2011 Mar 16.

7.

High prevalence of hypovitaminosis D status in patients with early Parkinson disease.

Evatt ML, DeLong MR, Kumari M, Auinger P, McDermott MP, Tangpricha V; Parkinson Study Group DATATOP Investigators.

Arch Neurol. 2011 Mar;68(3):314-9. doi: 10.1001/archneurol.2011.30.

PMID:
21403017
8.

Diabetes and risk of Parkinson's disease.

Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A, Chen H.

Diabetes Care. 2011 Apr;34(4):910-5. doi: 10.2337/dc10-1922. Epub 2011 Mar 4.

9.

Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes.

Yiu YF, Chan YH, Yiu KH, Siu CW, Li SW, Wong LY, Lee SW, Tam S, Wong EW, Cheung BM, Tse HF.

J Clin Endocrinol Metab. 2011 May;96(5):E830-5. doi: 10.1210/jc.2010-2212. Epub 2011 Feb 16.

PMID:
21325459
10.

Analysis of mutations and the association between polymorphisms in the cerebral dopamine neurotrophic factor (CDNF) gene and Parkinson disease.

Choi JM, Hong JH, Chae MJ, Ngyuen PH, Kang HS, Ma HI, Kim YJ.

Neurosci Lett. 2011 Apr 15;493(3):97-101. doi: 10.1016/j.neulet.2011.02.013. Epub 2011 Feb 12.

PMID:
21320571
11.

Vitamin D receptor gene as a candidate gene for Parkinson disease.

Butler MW, Burt A, Edwards TL, Zuchner S, Scott WK, Martin ER, Vance JM, Wang L.

Ann Hum Genet. 2011 Mar;75(2):201-10. doi: 10.1111/j.1469-1809.2010.00631.x.

12.

Intracellular trafficking and secretion of cerebral dopamine neurotrophic factor in neurosecretory cells.

Sun ZP, Gong L, Huang SH, Geng Z, Cheng L, Chen ZY.

J Neurochem. 2011 Apr;117(1):121-32. doi: 10.1111/j.1471-4159.2011.07179.x. Epub 2011 Feb 9.

13.

Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease.

Martella G, Madeo G, Schirinzi T, Tassone A, Sciamanna G, Spadoni F, Stefani A, Shen J, Pisani A, Bonsi P.

Neuroscience. 2011 Mar 17;177:240-51. doi: 10.1016/j.neuroscience.2010.12.057. Epub 2010 Dec 31.

PMID:
21195752
14.

Vitamin D metabolites and analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cell line.

Somjen D, Katzburg S, Grafi-Cohen M, Knoll E, Sharon O, Posner GH.

J Steroid Biochem Mol Biol. 2011 Jan;123(1-2):85-9. doi: 10.1016/j.jsbmb.2010.11.010. Epub 2010 Nov 24.

PMID:
21111046
15.
16.

Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: Potential role for dopamine transporter imaging.

Booij J, van Amelsvoort T, Boot E.

Am J Med Genet A. 2010 Nov;152A(11):2937-8. doi: 10.1002/ajmg.a.33665. No abstract available.

PMID:
20949509
17.

Maternal vitamin D deficiency alters the expression of genes involved in dopamine specification in the developing rat mesencephalon.

Cui X, Pelekanos M, Burne TH, McGrath JJ, Eyles DW.

Neurosci Lett. 2010 Dec 17;486(3):220-3. doi: 10.1016/j.neulet.2010.09.057. Epub 2010 Sep 25.

PMID:
20884326
18.

Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson's disease.

Li M, Zhang SZ, Guo YW, Cai YQ, Yan ZJ, Zou Z, Jiang XD, Ke YQ, He XY, Jin ZL, Lu GH, Su DQ.

Neurochem Res. 2010 Oct;35(10):1522-9. doi: 10.1007/s11064-010-0211-6. Epub 2010 Jul 24.

PMID:
20658188
19.

Serum vitamin D and the risk of Parkinson disease.

Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Sääksjärvi K, Heliövaara M.

Arch Neurol. 2010 Jul;67(7):808-11. doi: 10.1001/archneurol.2010.120.

20.

Bone density and metabolism in subjects with microdeletion of chromosome 22q11 (del22q11).

Stagi S, Lapi E, Gambineri E, Manoni C, Genuardi M, Colarusso G, Conti C, Chiarelli F, de Martino M, Azzari C.

Eur J Endocrinol. 2010 Aug;163(2):329-37. doi: 10.1530/EJE-10-0167. Epub 2010 Jun 1.

Supplemental Content

Support Center